These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 128278)

  • 41. [Position and developmental trends in fibrinolytic therapy].
    Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):6-17. PubMed ID: 2427416
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of fibrinolytic system by liquoid (polyanetholesulfonate). A contributing factor in the liquoid-induced renal cortical necrosis.
    Gilboa N; Ryan TJ; MacColl R
    Haemostasis; 1987; 17(3):162-70. PubMed ID: 3038710
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular biology of human plasminogen. II. Metabolism in physiological and some pathological conditions in man.
    Collen D; Verstraete M
    Thromb Diath Haemorrh; 1975 Nov; 34(2):403-8. PubMed ID: 1105875
    [No Abstract]   [Full Text] [Related]  

  • 44. Concepts of clot lysis.
    Francis CW; Marder VJ
    Annu Rev Med; 1986; 37():187-204. PubMed ID: 2939790
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The mechanisms of the activation of plasminogen by streptokinase and urokinase.
    Takada Y; Takada A
    Adv Exp Med Biol; 1990; 281():223-34. PubMed ID: 2102613
    [No Abstract]   [Full Text] [Related]  

  • 46. On the reliability of plasminogen measurement employing the proactivator-activator converting method.
    Martin M
    Thromb Haemost; 1976 Dec; 36(3):551-65. PubMed ID: 138961
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fibrin-specific fibrinolysis.
    Collen D; Lijnen HR
    Ann N Y Acad Sci; 1992 Dec; 667():259-71. PubMed ID: 1285022
    [No Abstract]   [Full Text] [Related]  

  • 48. [Mechanism of thrombolytic enzymes].
    Matsuo O
    Rinsho Ketsueki; 1993 Apr; 34(4):395-402. PubMed ID: 8510325
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Parallel induction of fibrinolysis and receptors for plasminogen and urokinase by interferon gamma on U937 cells.
    Lu H; Mirshahi M; Krief P; Soria C; Soria J; Mishal Z; Bertrand O; Perrot JY; Li H; Picot C
    Biochem Biophys Res Commun; 1988 Aug; 155(1):418-22. PubMed ID: 2843185
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of human plasminogen. II. Separation and partial characterization of different molecular forms of human plasminogen.
    Wallén P; Wiman B
    Biochim Biophys Acta; 1972 Jan; 257(1):122-34. PubMed ID: 4257942
    [No Abstract]   [Full Text] [Related]  

  • 51. Plasminogen activation: biochemistry, physiology, and therapeutics.
    Wun TC
    Crit Rev Biotechnol; 1988; 8(2):131-48. PubMed ID: 2976309
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Essential hyperlipemia and fibrinolysis].
    Blatny J; Kojecky Z; Fischerova E
    Nouv Rev Fr Hematol; 1968; 8(2):259-61. PubMed ID: 4232374
    [No Abstract]   [Full Text] [Related]  

  • 53. Fibrinolytic treatment by infusion of streptokinase-plasminogen-complex (activator): laboratory effects.
    Martin H; Auel H; Riedel C
    Behring Inst Mitt; 1986 Feb; (79):263-71. PubMed ID: 2424424
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular basis of fibrinolysis, as relevant for thrombolytic therapy.
    Collen D; Lijnen HR
    Thromb Haemost; 1995 Jul; 74(1):167-71. PubMed ID: 8578451
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Studies on the conformational changes of plasminogen induced during activation to plasmin and by 6-aminohexanoic acid.
    Sjöholm I
    Eur J Biochem; 1973 Nov; 39(2):471-9. PubMed ID: 4272770
    [No Abstract]   [Full Text] [Related]  

  • 56. Tissue plasminogen activator (tPA) inhibits plasmin degradation of fibrin. A mechanism that slows tPA-mediated fibrinolysis but does not require alpha 2-antiplasmin or leakage of intrinsic plasminogen.
    Wu JH; Diamond SL
    J Clin Invest; 1995 Jun; 95(6):2483-90. PubMed ID: 7769094
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Streptokinase-dependent delayed activation of horse plasminogen.
    Marcum JA; Highsmith RF; Kline DL
    Biochim Biophys Acta; 1982 Dec; 709(1):19-27. PubMed ID: 6217838
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].
    Veremeenko KN; Kizim AI
    Vopr Med Khim; 1984; 30(5):13-22. PubMed ID: 6084892
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A role for fibrinogen in the streptokinase-dependent acquisition of plasmin(ogen) by group A streptococci.
    Wang H; Lottenberg R; Boyle MD
    J Infect Dis; 1995 Jan; 171(1):85-92. PubMed ID: 7798686
    [TBL] [Abstract][Full Text] [Related]  

  • 60. H-D-val-leu-lys-aminoisophthalic acid, dimethyl ester, is sensitive to streptokinase-activator not to plasmin.
    Ts'ao C; Galluzzo TS
    Am J Clin Pathol; 1981 Mar; 75(3):372-7. PubMed ID: 6452054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.